Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
3.010
+0.080 (2.73%)
At close: Mar 24, 2026, 4:00 PM EDT
2.600
-0.410 (-13.62%)
After-hours: Mar 24, 2026, 6:18 PM EDT
Absci Market Cap
Absci has a market cap or net worth of $460.59 million as of March 24, 2026. Its market cap has increased by 28.53% in one year.
Market Cap
460.59M
Enterprise Value
321.60M
1-Year Change
28.53%
Ranking
Category
Stock Price
$3.01
Market Cap Chart
Since the IPO on July 22, 2021, Absci's market cap has increased from $423.19M to $460.59M, an increase of 8.84%. That is a compound annual growth rate of 1.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 440.59M | -16.05% |
| Dec 31, 2025 | 524.80M | 74.40% |
| Dec 31, 2024 | 300.92M | -22.91% |
| Dec 29, 2023 | 390.34M | 101.18% |
| Dec 30, 2022 | 194.03M | -74.44% |
| Dec 31, 2021 | 759.25M | 79.41% |
| Jul 22, 2021 | 423.19M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prothena Corporation | 469.96M |
| 4D Molecular Therapeutics | 468.65M |
| Rocket Pharmaceuticals | 463.59M |
| enGene Holdings | 462.23M |
| Contineum Therapeutics | 460.35M |
| Lyell Immunopharma | 459.15M |
| Upstream Bio | 456.63M |
| Maravai LifeSciences Holdings | 450.86M |